• SGI-1027 (SKU B1622): Reliable DNMT Inhibition for Cancer Ep

  2026-05-27

  This article provides a scenario-driven guide to overcoming common laboratory challenges with cell viability and epigenetics assays using SGI-1027 (SKU B1622). Drawing on validated workflows and comparisons, it demonstrates how this DNA methyltransferase inhibitor from APExBIO supports reproducible, quantitative cancer research.

• Bazedoxifene: Translational Leverage Beyond Osteoporosis

  2026-05-26

  Bazedoxifene, a third-generation selective estrogen receptor modulator (SERM), is celebrated for its robust efficacy in osteoporosis treatment research. This article provides a mechanistic deep-dive and strategic roadmap for translational researchers, exploring not only Bazedoxifene's established role in bone mineral density enhancement but also its emerging repurposing potential as an antimalarial agent. Integrating recent evidence, protocol guidance, and cross-domain insights, we chart a course for innovative applications in estrogen receptor signaling pathway research and beyond.

• ω-Agatoxin IVA TFA (SKU C8722): Precision Tools for Neuropro

  2026-05-26

  This article explores how ω-Agatoxin IVA TFA (SKU C8722) addresses common challenges in neuronal calcium current recording, synaptic transmission research, and epilepsy models. By integrating scenario-driven Q&A and referencing quantitative literature, we demonstrate the reagent’s reproducibility, selectivity, and workflow compatibility for advanced neurophysiology experiments.

• NLRP3 Knockdown Modulates Pyroptosis and Ferroptosis in DCM

  2026-05-25

  Wang et al. (2024) elucidate the mechanistic relationship between NLRP3 inflammasome activity, mitochondrial ROS, and regulated cell death pathways—pyroptosis and ferroptosis—in diabetic cardiomyopathy. Their findings reveal that NLRP3 knockdown protects cardiac cells from high-glucose-induced injury, and that mitochondrial ROS promotion can override this protection, highlighting potential therapeutic targets for diabetic heart disease.

• Technical Guide: YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-y

  2026-05-25

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol addresses the need for precise inhibition of hypoxia-inducible factor 1 transcriptional activity in cancer biology workflows, particularly under hypoxic conditions. It is best applied in controlled research settings for studying tumor angiogenesis inhibition and apoptosis, but is not suitable for diagnostic or therapeutic use.

• Diuron in Translational Science: Mechanistic and Strategic I

  2026-05-24

  Explore how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) is redefining translational research at the intersection of plant biology, toxicology, and human health. This article provides a deep dive into recent mechanistic discoveries, including the JAK2/STAT1-mediated nephrotoxicity, and delivers actionable strategies for researchers leveraging APExBIO’s high-purity Diuron. Integrating cross-domain advances, competitive context, and advanced protocol guidance, the piece addresses both fundamental scientific questions and practical translational pathways.

• Mitochondrial CAT-Tailing Drives Glioblastoma Growth via RQC

  2026-05-23

  This study uncovers a mechanistic link between mitochondrial protein CAT-tailing, a ribosome-associated quality control (RQC) process, and the enhanced survival of human glioblastoma cells. By demonstrating that CAT-tailed mitochondrial proteins increase mitochondrial membrane potential and inhibit apoptosis, the research offers new insight into metabolic adaptations in aggressive brain tumors.

• Excessive Calpain Disrupts BDNF/TrkB, Impairing Offspring Co

  2026-05-22

  A recent study reveals that maternal surgery during pregnancy elevates calpain activity in offspring, leading to cognitive deficits via BDNF/TrkB pathway dysregulation. Pharmacological calpain inhibition with MDL 28170 partially restores synaptic integrity and function, highlighting a potential therapeutic avenue for neuroprotection in developmentally vulnerable populations.

• SGC-CBP30: Selective CREBBP/EP300 Bromodomain Inhibitor Insi

  2026-05-22

  SGC-CBP30 is a highly selective CREBBP/EP300 bromodomain inhibitor that enables precise interrogation of epigenetic and transcriptional regulation. Its nanomolar potency, chemical stability, and demonstrated efficacy in cancer biology research make it a valuable tool for dissecting mechanisms such as super-enhancer-driven oncogenesis.

• Bazedoxifene as an Antimalarial: Inhibition of Hemozoin Form

  2026-05-21

  This study demonstrates that Bazedoxifene, a third-generation selective estrogen receptor modulator, exhibits potent antimalarial activity by inhibiting hemozoin formation in Plasmodium falciparum. The findings highlight a promising repurposing opportunity, bridging osteoporosis treatment research and malaria therapy.

• 3X (DYKDDDDK) Peptide: Precision Tagging for Structural Biol

  2026-05-21

  Explore how the 3X (DYKDDDDK) Peptide enables high-fidelity protein tagging, purification, and structural analysis. This article reveals its scientific advantages for crystallography and metal-dependent assays, offering unique insights beyond standard workflows.

• Tin Mesoporphyrin IX: Precision Heme Oxygenase Inhibition in

  2026-05-20

  Tin Mesoporphyrin IX (chloride) empowers metabolic and virology researchers with nanomolar, reproducible inhibition of heme oxygenase, streamlining both in vitro and in vivo workflows. Its reliable, high-affinity profile and robust performance make it a gold standard for dissecting heme catabolism and redox signaling in complex disease models.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Applied Workflow

  2026-05-20

  The One-step TUNEL Cy3 Apoptosis Detection Kit delivers sensitive and robust detection of apoptotic DNA fragmentation in tissue sections and cultured cells. Streamlined protocols, Cy3-based fluorescence, and high specificity make it a standout choice for apoptosis research, especially where clear discrimination between apoptosis and closely related pathways is required.

• K+ Channel Blockade Worsens Renal Blood Flow in Septic Rats

  2026-05-19

  This study investigates how blocking ATP-sensitive and calcium-activated potassium channels affects renal blood flow in septic rats treated with norepinephrine or phenylephrine. The findings reveal that certain channel blockers, when combined with vasoactive agents, can exacerbate reductions in kidney perfusion, offering mechanistic insights valuable for vascular biology and sepsis research.

• Resiniferatoxin (RTX): Strategic Guidance for Translational

  2026-05-19

  This article delivers actionable insights for translational researchers working with Resiniferatoxin (RTX), focusing on its mechanistic impact on TRPV1-positive sensory neurons, immune modulation, and protocol optimization. It integrates recent evidence from preclinical and immunological studies, contextualizes RTX within the competitive landscape, and provides a forward-looking outlook grounded in cited findings. Strategic guidance is offered to accelerate translational advances while highlighting APExBIO’s RTX as a gold-standard research tool.

390 records 6/26 page Previous Next First page 上5页 678910 下5页 Last page